Moody’s also affirmed the “A2” rating on Riverside’s existing series 2013, series 2009 and series 2006C bonds, affecting approximately $124 million of outstanding revenue bonds issued through the Illinois Finance Authority.
The rating assignment and affirmation are based on several factors, including Riverside’s solid liquidity and track record of strong operating performance.
The outlook is stable, reflecting Riverside’s leading market position and Moody’s Investors Service’s expectation that its liquidity will remain consistent.
More articles on healthcare finance:
S&P raises Covenant Health’s bond ratings to ‘A’
Fitch revises Nebraska Methodist Health System’s outlook to positive
Moody’s affirms King’s Daughters’ Health’s ‘Baa2’ rating
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
